Ipratropium bromide and salbutamol (nebulized)

ipratropium bromide; salbutamol · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ipratropium bromide and salbutamol (nebulized), covering 2017-10-11 to 2017-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD [Phase 4]